Brain [F-18]FDG PET for Clinical Dementia Workup: Differential Diagnosis of Alzheimer's Disease and Other Types of Dementing Disorders

2021 ◽  
Vol 51 (3) ◽  
pp. 230-240 ◽  
Author(s):  
Satoshi Minoshima ◽  
Karina Mosci ◽  
Donna Cross ◽  
Tanyaluck Thientunyakit
2016 ◽  
Vol 37 (1) ◽  
pp. 252-262 ◽  
Author(s):  
Dmitry Titov ◽  
Janine Diehl-Schmid ◽  
Kuangyu Shi ◽  
Robert Perneczky ◽  
Na Zou ◽  
...  

Presently, visual and quantitative approaches for image-supported diagnosis of dementing disorders rely on regional intensity rather than on connectivity measurements. Here, we test metabolic connectivity for differentiation between Alzheimer’s disease and frontotemporal lobar degeneration. Positron emission tomography with 18F-fluorodeoxyglucose was conducted in 47 patients with mild Alzheimer’s disease, 52 patients with mild frontotemporal lobar degeneration, and 45 healthy elderly subjects. Sparse inverse covariance estimation and selection were used to identify patterns of metabolic, inter-subject covariance on the basis of 60 regional values. Relative to healthy subjects, significantly more pathological within-lobe connections were found in the parietal lobe of patients with Alzheimer’s disease, and in the frontal and temporal lobes of subjects with frontotemporal lobar degeneration. Relative to the frontotemporal lobar degeneration group, more pathological connections between the parietal and temporal lobe were found in the Alzheimer’s disease group. The obtained connectivity patterns differentiated between two patients groups with an overall accuracy of 83%. Linear discriminant analysis and univariate methods provided an accuracy of 74% and 69%, respectively. There are characteristic patterns of abnormal metabolic connectivity in mild Alzheimer’s disease and frontotemporal lobar degeneration. Such patterns can be utilized for single-subject analyses and might be more accurate in the differential diagnosis of dementing disorders than traditional intensity-based analyses.


2014 ◽  
Vol 10 ◽  
pp. P400-P400
Author(s):  
Jonas Jardim de Paula ◽  
Maria Aparecida Bicalho ◽  
Fernanda Carvalho ◽  
Marcelo Mamede ◽  
Laiss Bertola ◽  
...  

2020 ◽  
Vol 77 (3) ◽  
pp. 935-947
Author(s):  
Cyrus A. Raji ◽  
Nare Torosyan ◽  
Daniel H. S. Silverman

Alzheimer’s disease (AD) is the most common neurodegenerative disease and is characterized by preclinical, pre-dementia, and dementia phases. Progression of the disease leads to cognitive decline and is associated with loss of functional independence, personality changes, and behavioral disturbances. Current guidelines for AD diagnosis include the use of neuroimaging tools as biomarkers for identifying and monitoring pathological changes. Various imaging modalities, namely magnetic resonance imaging (MRI), fluorodeoxyglucose-positron emission tomography (FDG-PET) and PET with amyloid-beta tracers are available to facilitate early accurate diagnoses. Enhancing diagnosis in the early stages of the disease can allow for timely interventions that can delay progression of the disease. This paper will discuss the characteristic findings associated with each of the imaging tools for patients with AD, with a focus on FDG-PET due to its established accuracy in assisting with the differential diagnosis of dementia and discussion of other methods including MRI. Diagnostically-relevant features to aid clinicians in making a differential diagnosis will also be pointed out and multimodal imaging will be reviewed. We also discuss the role of quantification software in interpretation of brain imaging. Lastly, to guide evaluation of patients presenting with cognitive deficits, an algorithm for optimal integration of these imaging tools will be shared. Molecular imaging modalities used in dementia evaluations hold promise toward identifying AD-related pathology before symptoms are fully in evidence. The work describes state of the art functional and molecular imaging methods for AD. It will also overview a clinically applicable quantitative method for reproducible assessments of such scans in the early identification of AD.


2013 ◽  
Vol 9 ◽  
pp. P386-P386
Author(s):  
Yuhei Chiba ◽  
Eizo Iseki ◽  
Hiroshige Fujishiro ◽  
Kazumi Ota ◽  
Koji Kasanuki ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document